Terry L. Lierman - 17 Oct 2025 Form 4 Insider Report for IGC Pharma, Inc. (IGC)

Reporting relationship
Director
Issuer ticker
IGC
Reported as of
17 Oct 2025
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
21 Oct 2025, 08:47:45 UTC
Prior SEC filing
15 Mar 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Terry L. Lierman

Key filing fact

Terry L. Lierman filed Form 4 for IGC Pharma, Inc. (IGC) on 21 Oct 2025.

Key facts

  • This page summarizes Terry L. Lierman's Form 4 filing for IGC Pharma, Inc. (IGC).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 21 Oct 2025, 08:47.

Change

  • Previous filing in this sequence was filed on 15 Mar 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002014677 Primary reporting owner

LIERMAN TERRY L

Relationship
Director
Address
10224 FALLS ROAD, POTOMAC
Signature
/s/ Terry L. Lierman
Signature date
21 Oct 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IGC transaction Derivative

Options

Award

Transaction value
$0
Shares
+500,000
Change %
Price
$0.000000
Shares after
500,000
Date
17 Oct 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
500,000
Exercise price
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Reporting Person was granted 500,000 options exercisable at $0.35, equally vesting over the next three years starting in March 31st 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .